M. Ramírez Martín, E. Fernández Fernández, J. Muñoz Serrano, A. Abbasi Pérez
{"title":"类风湿关节炎患者贫血的诊断和治疗方案","authors":"M. Ramírez Martín, E. Fernández Fernández, J. Muñoz Serrano, A. Abbasi Pérez","doi":"10.1016/j.med.2025.05.015","DOIUrl":null,"url":null,"abstract":"<div><div>Anemia is one of the most frequent extra-articular manifestations and the most common hematologic disorder in patients with rheumatoid arthritis. The most frequent are anemia of chronic disease (ACD), which is usually mild normocytic normochromic and asymptomatic, and iron-deficiency anemia. Macrocytic, hemolytic, and drug-induced anemia occur less frequently. Its prevalence in rheumatoid arthritis ranges from 30% to 70%, depending on the series studied. ACD is due to a combination of reduced iron availability in peripheral blood and decreased erythroid formation in the bone marrow. It is fundamental to identify the cause in order to establish treatment, as anemia in rheumatoid arthritis is often assumed to be due to chronic disorders and is sometimes inadequately treated by intensifying treatment with disease-modifying drugs.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 33","pages":"Pages 2021-2025"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Protocolo diagnóstico y terapéutico de la anemia en pacientes con artritis reumatoide\",\"authors\":\"M. Ramírez Martín, E. Fernández Fernández, J. Muñoz Serrano, A. Abbasi Pérez\",\"doi\":\"10.1016/j.med.2025.05.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Anemia is one of the most frequent extra-articular manifestations and the most common hematologic disorder in patients with rheumatoid arthritis. The most frequent are anemia of chronic disease (ACD), which is usually mild normocytic normochromic and asymptomatic, and iron-deficiency anemia. Macrocytic, hemolytic, and drug-induced anemia occur less frequently. Its prevalence in rheumatoid arthritis ranges from 30% to 70%, depending on the series studied. ACD is due to a combination of reduced iron availability in peripheral blood and decreased erythroid formation in the bone marrow. It is fundamental to identify the cause in order to establish treatment, as anemia in rheumatoid arthritis is often assumed to be due to chronic disorders and is sometimes inadequately treated by intensifying treatment with disease-modifying drugs.</div></div>\",\"PeriodicalId\":100912,\"journal\":{\"name\":\"Medicine - Programa de Formación Médica Continuada Acreditado\",\"volume\":\"14 33\",\"pages\":\"Pages 2021-2025\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicine - Programa de Formación Médica Continuada Acreditado\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0304541225001301\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225001301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Protocolo diagnóstico y terapéutico de la anemia en pacientes con artritis reumatoide
Anemia is one of the most frequent extra-articular manifestations and the most common hematologic disorder in patients with rheumatoid arthritis. The most frequent are anemia of chronic disease (ACD), which is usually mild normocytic normochromic and asymptomatic, and iron-deficiency anemia. Macrocytic, hemolytic, and drug-induced anemia occur less frequently. Its prevalence in rheumatoid arthritis ranges from 30% to 70%, depending on the series studied. ACD is due to a combination of reduced iron availability in peripheral blood and decreased erythroid formation in the bone marrow. It is fundamental to identify the cause in order to establish treatment, as anemia in rheumatoid arthritis is often assumed to be due to chronic disorders and is sometimes inadequately treated by intensifying treatment with disease-modifying drugs.